Literature DB >> 29338054

Correction: Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition.

Andreas Austgulen Westin, Malin Brekke, Espen Molden, Eirik Skogvoll, Olav Spigset.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0181082.].

Entities:  

Year:  2018        PMID: 29338054      PMCID: PMC5770058          DOI: 10.1371/journal.pone.0191508

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


The affiliation for the 1st author is incomplete. Andreas Austgulen Westin is affiliated with #1 and #6. There is an error in the caption for Fig 1, “Inclusion flow chart.” Please see the complete, correct Fig 1 caption here.
Fig 1

Inclusion flow chart.

Sample identification and inclusion of therapeutic drug monitoring samples of selective serotonin reuptake inhibitors and venlafaxine obtained during pregnancy. a Five analyses were excluded due to the following drug interactions: sertraline + carbamazepine (n = 1), venlafaxine + bupropion (n = 4).

Inclusion flow chart.

Sample identification and inclusion of therapeutic drug monitoring samples of selective serotonin reuptake inhibitors and venlafaxine obtained during pregnancy. a Five analyses were excluded due to the following drug interactions: sertraline + carbamazepine (n = 1), venlafaxine + bupropion (n = 4).
  1 in total

1.  Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition.

Authors:  Andreas Austgulen Westin; Malin Brekke; Espen Molden; Eirik Skogvoll; Olav Spigset
Journal:  PLoS One       Date:  2017-07-14       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.